Modified pyrimidine glucocorticoid receptor modulators

Details for Australian Patent Application No. 2005270039 (hide)

Owner Corcept Therapeutics, Inc.

Inventors Ray, Nicholas C.; Clark, Robin D.; Williams, Karen; Hickin, Gwen; Clark, David A.; Crackett, Peter H.

Agent FB Rice

Pub. Number AU-B-2005270039

PCT Pub. Number WO2006/014394

Priority 60/585,018 02.07.04 US

Filing date 29 June 2005

Wipo publication date 9 February 2006

Acceptance publication date 1 September 2011

International Classifications

C07D 419/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

Event Publications

25 January 2007 PCT application entered the National Phase

  PCT publication WO2006/014394 Priority application(s): WO2006/014394

1 September 2011 Application Accepted

  Published as AU-B-2005270039

12 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005270047-Dental light device having an improved heat sink

2005270037-Endoscopic imaging probe comprising dual clad fibre